Penwest Pharmaceutical
2981 Route 22
Patterson
New York
12563-9970
United States
Tel: 914-878-3414
137 articles about Penwest Pharmaceutical
-
Penwest Pharmaceutical Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals
11/5/2010
-
Penwest Pharmaceutical Announces Intention to Terminate NASDAQ Listing and Registration
10/18/2010
-
Penwest Pharmaceutical Sets Special Shareholders Meeting Date for Approval of Merger With Subsidiary of Endo Pharmaceuticals
10/1/2010
-
Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceutical
9/21/2010
-
Endo Pharmaceuticals to Buy Penwest Pharmaceutical for About $168 Million and Submits NDA For New Formulation of Long-Acting Oxymorphone Designed to be Crush-Resistant
8/10/2010
-
Penwest Pharmaceutical Q2 Revenues Up, but Job Cuts Likely
8/5/2010
-
Penwest Pharmaceutical Reports Record Revenue and Earnings for Second Quarter of 2010
8/4/2010
-
Penwest Pharmaceutical's Board Approves Corporate Governance Changes and Selects New Chairman
8/2/2010
-
Penwest Pharmaceutical to Present at Upcoming Conferences
7/29/2010
-
Shareholders of Penwest Pharmaceutical Elect Tang Capital and Perceptive Nominees to the Board
6/22/2010
-
Proxy Advisory Groups Recommend Shareholders of Penwest Pharmaceutical Vote on Tang Capital and Perceptive Life Sciences Master Fund Ltd. GOLD Proxy Card
6/14/2010
-
Endo Pharmaceuticals and Penwest Pharmaceutical Enter Into Agreement with Sandoz to Settle OPANA(R) ER Patent Litigation
6/8/2010
-
Tang Capital Partners LP and Perceptive Life Sciences Master Fund Ltd. Urge the Shareholders of Penwest Pharmaceutical to Vote for Their Director Nominees
6/7/2010
-
Penwest Pharmaceutical Urges Shareholders to Vote "For" Three Current Directors and Reject Tang/Edelman Slate
5/17/2010
-
Penwest Pharmaceutical Reports First Quarter 2010 Financial Results
5/3/2010
-
Penwest Pharmaceutical Provides Update on Recent Business Progress and Corporate Governance Developments
4/23/2010
-
Endo Pharmaceuticals and Penwest Pharmaceutical Enter Into Agreement with Barr Pharmaceuticals, Inc. to Settle Patent Litigation Over Opana(R) ER
4/13/2010
-
Penwest Pharmaceutical Signs Multi-Drug Generics Agreement With Alvogen
4/9/2010
-
Penwest Pharmaceutical Reports Fourth Quarter and Year End 2009 Financial Results
3/4/2010
-
Penwest Pharmaceutical to Present at Cowen and Company 30th Annual Healthcare Conference
3/3/2010